Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Mead Johnson Nutrition
Mead Johnson Nutrition
(MJN)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Mucomyst w/ isoproterenol
Acetylcysteine
,
Isoproterenol
1982-01-01
2025-2032
Respiratory distress syndrome
,
Pneumonia
,
Cystic fibrosis
,
Bronchiectasis
,
Bronchitis
,
Amyloidosis
,
Pulmonary emphysema
,
Poisoning
,
Septic shock
,
Low cardiac output
,
Bradycardia
,
Heart arrest
,
Ventricular fibrillation
,
Hemorrhagic shock
,
Torsades de pointes
,
Adams-stokes syndrome
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Doconexent
myocardial infarction
,
coronary disease
,
infarction
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use